AZD8421の発見:他のCDKファミリーメンバーとヒトキノームに対する選択性を持つ強力なCDK2阻害剤
Avipsa Ghosh1, Afshan Ahmed2, Konstantina Amoiradaki2
1Chemistry, Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.
Journal of medicinal chemistry
|September 3, 2025
まとめ
新しい薬であるAZD8421は,サイクリン依存キナーゼ2 (CDK2) の強力で選択的な阻害剤です. この発見は,毒性の問題を克服し,がん治療における耐性メカニズムをターゲットにすることができます.
科学分野:
- 腫瘍学
- 分子生物学
- 薬物の発見
背景:
- 第1世代のサイクリン依存キナーゼ2 (CDK2) 阻害剤は,選択性低下と標的外毒性により,限られた治療指数を示した.
- CDK2は,特にサイクリンE発現が高く,CDK4/ 6阻害剤に対する耐性に関与しています.
研究 の 目的:
- 新しい,高度に選択的なCDK2阻害剤を発見し,特徴づけること.
- 高いサイクリンE/CDK2活性によって誘発される耐性メカニズムを標的とし,標的外効果を最小限に抑える治療薬を開発する.
主な方法:
- 強力で選択的なCDK2阻害剤であるAZD8421の発見とプロファイリング.
- AZD8421の選択性の評価は,CDKファミリーとヒトのキノームに対するものです.
- AZD8421の薬動学的特性 (溶解性,安定性) の評価
- 卵巣がん患者からの異種移植モデルでAZD8421の有効性を試験する.
主要な成果:
- AZD8421は,CDK1よりも,他のCDKとキノームに対する優れた選択性を示した.
- この化合物は,良好な溶解性およびin vitro安定性を含む好ましい薬動性を示した.
- AZD8421は卵巣がん患者からの異種移植モデルで有効性を示した.
結論:
- AZD8421は強力な,高度に選択的なCDK2阻害剤であり,潜在的治療用途があります.
- 選択性プロファイルと実証された有効性は,以前のCDK2阻害剤の限界を克服し,耐性メカニズムに対処できることを示唆しています.
関連する概念動画
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
S-Cdk Initiates DNA Replication
4.8K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.8K


